Recurrent Exon-Deleting Activating Mutations in AHR Act as Drivers of Urinary Tract Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer
Sci Rep 2022 Jun 16;12(1)10081, JM Vlaar, A Borgman, E Kalkhoven, D Westland, N Besselink, C Shale, BM Faltas, P Priestley, E Kuijk, E CuppenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.